Trial Profile
A Prospective Multicenter Cohort Study of Late Physical Psychological and Social Effects in Patients Treated With Ipilimumab for Advanced Melanoma
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Sep 2020
Price :
$35
*
At a glance
- Drugs Ipilimumab (Primary)
- Indications Malignant melanoma
- Focus Adverse reactions
- Sponsors Bristol-Myers Squibb
- 09 Sep 2020 Status changed from recruiting to completed.
- 10 Jul 2018 Planned End Date changed from 7 May 2018 to 30 Oct 2020.
- 10 Jul 2018 Planned primary completion date changed from 7 May 2018 to 29 May 2020.